Prohibited/Pharmaceutical
Butanilicaine dihydrogen phosphate
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A local anesthetic pharmaceutical drug that is explicitly prohibited from use in EU cosmetic products. It is not a cosmetic ingredient and carries genuine pharmacological risks if applied to the skin.
Skin benefits
- No cosmetic benefits, this is a local anesthetic drug
- Historical pharmaceutical use only under medical supervision
Known concerns
- EU Annex II prohibited substance in cosmetics
- Pharmaceutical local anesthetic with systemic toxicity risk
- Can cause cardiac and CNS effects if absorbed
- Not a legitimate cosmetic ingredient
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related prohibited/pharmaceuticals
Check your shelf
Find Butanilicaine dihydrogen phosphate in your products.
Scan any cosmetic product with LuxSense to see if it contains Butanilicaine dihydrogen phosphate and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.